Phenotypic variables such as smoking history and occupational exposures were significators predictors of head and neck cancer risk.

A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck squamous cell carcinoma (HNSCC).

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against solid tumors and infectious diseases, announced today that the U.S. Patent and ...

COVID-19 vaccine program progressing with additional data evaluating GEO-CM04S1 as booster to mRNA vaccines in healthy adults expected in second quarter of 2025  Clinical evaluation of GEO-MVA, ...

Previously, the drug has been approved in China for nasopharyngeal carcinoma, a rare cancer that develops in ... trial proves that ivonescimab’s head-to-head win against Keytruda as NSCLC ...

TG4050: Updated randomized Phase I data to be presented in Rapid Oral Presentation at ASCO 2025 Dr. Simone Steiner appointed Chief Technical Officer (CTO) Business funded until the end of April 2026 ...

The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

Dr. Gollin “pioneered important discoveries in the field of head and neck cancer,” according to an April 8 news release from the University of Pittsburgh. She patented the observation that ...

Undifferentiated round cell sarcoma is a rare form of cancer that affects roughly one in a million Americans, according to Medical News Today. Martin began chemotherapy treatment in February.

A dentist in Golden Valley is urging people to be screened for head and neck cancer. “Everyone should be screened because it’s not only those people that are in those risk categories, it really can ...